Purpose

This study aims to characterize key mechanisms underlying the development, maintenance, and treatment of severe irritability in a clinically heterogeneous sample of school-aged youth.

Condition

Eligibility

Eligible Ages
Between 4 Years and 17 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Children between the ages of 4-17 years - (a) a principal diagnosis of an anxiety or mood disorder per DSM-5 criteria, OR (b) parent report of clinically impairing irritability, emotional dysregulation, and/or disruptive behavior in youth - Child and parent must be able to complete consent documents, assessments, and participate in treatment in English without a translator - At least one parent must be available and willing to participant in both phases.

Exclusion Criteria

  • Gross neurological, sensory, or motor impairment - History of seizure disorder, psychosis, or organic brain syndrome - Conditions requiring acute intervention, e.g., active suicidality - Non-English speaking child or parent

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Intervention Model Description
Standard evidence-based intervention based on child's primary diagnosis.
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Treatment Group
  • Behavioral: Cognitive Behavioral Therapy
    Participants will receive evidence-based treatment designed to address a wide range of emotional disorders.

Recruiting Locations

More Details

Status
Recruiting
Sponsor
Florida State University

Study Contact

Sherelle Harmon, PhD
18506458724
harmonylab@psy.fsu.edu

Detailed Description

Severe irritability in youth is associated with significant functional impairment and occurs across diagnostic categories. This study aims to characterize key mechanisms underlying the development, maintenance, and treatment of severe irritability in a clinically heterogeneous sample of school-aged youth. Participants will complete (a) a comprehensive, multimodal assessment - including diagnostic interviews, multi-informant behavioral ratings, and neurophysiological tasks - to evaluate core cognitive, behavioral, and psychosocial factors, and (b) evidence-based treatment (e.g., cognitive behavioral therapy). Repeated assessments throughout the study period will be used to evaluate study outcomes.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.